|
|
|
|
Events > HPV Workshop > Programme |
|
|
|
|
|
|
|
2nd ICGEB Workshop on Human papillomavirus: From Basic Biology to Cancer Prevention |
|
|
|
|
Scientific Programme - Day 1 - 8th Nov 2016 |
Time |
Topic |
Speaker |
09:15-09:30 |
Opening Ceremony |
Opening Lecture |
09:30-10:00 |
The spectrum of HPV-associated clinical problems |
Paul CHAN, Hong Kong |
Session I.a – Basic Science I
Chairpersons: Lawrence BANKS, Italy; Martin WONG, Hong Kong |
10:00-10:30 |
The Papillomavirus life cycle at different epithelial sites |
John DOORBAR, UK |
10:30-11:00 |
HPV virion structure and assembly |
Robert GARCEA, USA |
11:00-11:30 |
Coffee & poster |
Session 1.b – Epidemiology I
Chairpersons: Ryo KONNO, Japan; Carmen WONG, Hong Kong |
11:30-12:00 |
HPV genotyping - the Korean perspective |
JS PARK, Korea |
12:00-12:30 |
Cervical cancer prevention: The Taiwan perspective |
TY CHU, Taiwan |
12:30-12:45 |
Cost-consequences analysis of HPV vaccination in the Hong Kong setting |
Barry YEUNG, Hong Kong |
12:45-13:00 |
Role of condyloma accuminata in incident HIV infection: a population-based cohort study in Taiwan 2000-2010 |
Huachun ZOU, China |
13:00-14:00 |
Lunch Symposium |
Session 1.c – Cervical Screening
Chairpersons: MY YU, Hong Kong; YL WOO, Malaysia |
14:00-14:30 |
Cytology and HPV tests – Yin and Yang in cervical cancer screening |
Annie CHEUNG, Hong Kong |
14:30-15:00 |
Is self-sampling a solution for cervical screening? |
Eliza WONG, Hong Kong |
15:00-15:15 |
A cross-sectional study on Cobas HPV testing for cervical cancer screening in 11064 Chinese women |
Qiongyan WU, China |
15:15-15:30 |
Predictive value of three different methods in screening of cervical cancer within 1,111 cases |
Xufeng WU, China |
15:30-16:00 |
Coffee & poster |
Session 1.d – Translation & Novel Applications
Chairpersons: TY CHU, Taiwan; SF YIM, Hong Kong |
16:00-16:30 |
Road to eradicating cervical cancer through translational and implementation science |
YL WOO, Malaysia |
16:30-17:00 |
Translation of HPV mediated immortalization to cancer precision medicine |
Xuefeng LIU, USA |
17:00-17:15 |
Early prediction of molecular biomarkers for therapy resistance in cervical cancers |
Lih Wen DENG, Singapore |
17:15-17:30 |
The value of human papillomavirus DNA detection and type 16/18 genotyping by hybrid capture 2 in primary screening for cervical cancer |
Xiumin ZHAO, China |
17:30-17:45 |
Development of a salivary HPV-16 DNA assay to detect oropharyngeal cancers |
Chamindie PUNYADEERA, Australia |
|
|
Scientific Programme - Day 2 - 9th Nov 2016 |
Time |
Topic |
Speaker |
Session 2.a – Basic Science II
Chairpersons: Robert GARCEA, USA; John DOORBAR, UK |
09:30-10:00 |
Endosomal sorting pathways and HPV entry mechanisms |
Lawrence BANKS, Italy |
10:00-10:30 |
HPV and noncoding RNAs |
Zhi-Ming ZHENG, USA |
10:30-10:45 |
Effect of arecoline on human papillomavirus 16 long control region and oncostain M upregulation by miR-22 suppression |
Jureeporn CHUERDUANGPHUI, Thailand |
10:45-11:00 |
The HPV-18 E6 oncoprotein regulates CD40 expression via the AT-Hook transcription factor AKNA |
Joaquin MANZO-MERINO, Mexico |
11:00-11:15 |
Association of human papillomavirus and Epstein-Barr virus infection with gene promoter methylation of O-Methyl guanine methyltransferase in nasopharyngeal carcinoma |
Nuchsupha SUNTHAMALA, Thailand |
11:15-11:30 |
Coffee & poster |
Session 2.b – Epidemiology II
Chairpersons: Qinjian ZHAO, China; Jo CHEUNG, Hong Kong |
11:30-12:00 |
Cervical cancer screening with HPV testing and cytology in Japan. Trial and early introduction |
Ryo KONNO, Japan |
12:00-12:15 |
P53 exon 8 codon 282 gene status in human papillomaviruses (HPV)-associated oral squamous cell carcinoma (OSCC) |
Pensiri PHUSINGHA, Thailand |
12:15-12:30 |
HPV infection- link to oral hygiene? |
Kai Dun TANG, Australia |
12:30-12:45 |
Salivary biomarkers for detection of human papillomavirus (HPV) - and Epstein-Barr virus (EBV)-related oral squamous cell carcinoma (OSCC) |
Chukkris HEAWCHAIYAPHUM, Thailand |
12:45-13:00 |
Differential expression of the collagen receptor, DDR1, and collagens Xla1 and VIIIa1 in HPV-negative and -positive oropharyngeal cancer |
Sook Ling LAI, Malaysia |
13:00-14:00 |
Lunch Symposium |
Session 2.c – Vaccine
Chairpersons: Siaw S BOON, Hong Kong; John DOORBAR, UK |
14:00-14:30 |
Unveiling the neutralizing epitopes of human papillomavirus |
Qinjian ZHAO, China |
14:30-15:00 |
New approaches to prophylactic HPV vaccines for cervical cancer prevention |
Robert GARCEA, USA |
15:00-15:30 |
HPV therapeutic vaccine |
JS PARK, Korea |
15:30-16:00 |
Coffee & poster |
Session 2.d – Evolution, classification & variants
Chairpersons: JS PARK, Korea; Eddy LAM, Hong Kong |
16:00-16:30 |
Human papillomavirus and human migration: partnership of millions years |
TY CHU, Taiwan |
16:30-17:00 |
Classification & evolution of papillomavirus |
Zigui CHEN, Hong Kong |
17:00-17:30 |
The Asian HPV 52/58 variants |
Paul CHAN, Hong Kong |
|
|
Scientific Programme - Day 3 - 10th Nov 2016 |
Time |
Topic |
Speaker |
Session 3.a – Basic Science III
Chairpersons: Xuefeng LIU, USA; Zhi-Ming ZHENG, USA |
09:30-10:00 |
The role of HPV E6-PDZ interactions in the development of malignancy |
Lawrence BANKS, Italy |
10:00-10:30 |
3D tissue models for anti-HPV target discovery and drug validation |
Thomas BROKER, USA |
10:30-10:45 |
Exosomes from EBV-infected lymphocytes in cervical lesions induced interferon-related gene expression in dendritic cells |
Sirinart AROMSEREE, Thailand |
10:45-11:00 |
Protein profiling in human cervical keratinocytes transduced with E6D25E of human papillomavirus type 16 Asian variant |
Peechanika CHOPJITT, Thailand |
11:00-11:15 |
Synergistic effect of E6/E7-specific siRNA with chemotherapeutic agents regulates the dynamics of TP53 and RB/E2F signaling for cell-fate control |
Nirmal RAJASEKARAN, South Korea |
11:15-11:30 |
Coffee & poster |
Session 3.b – Non-anogenital Lesions
Chairpersons: Zigui CHEN, Hong Kong; Alexander VLANTIS, Hong Kong |
11:30-12:00 |
The prevalence of and factors associated with oral Human Papillomavirus infection: a population-based screening programme |
Martin WONG, Hong Kong |
12:00-12:30 |
HPV and orophayngeal cancer: the Hong Kong scene |
Eddy LAM, Hong Kong |
12:30-13:00 |
Presentation of Cutaneous HPV lesions and management of common wart |
NM LUK, Hong Kong |
13:00-13:15 |
Fanconi anemia and oral human papillomavirus |
PORTUGAL Magda, Brazil |
13:15-14:00 |
Lunch & poster |
Session 3.c – General Cancer Biology
Chairpersons: Thomas BROKER, USA; Alfred CHENG, Hong Kong |
14:00-14:30 |
The role of EBV infection in the pathogenesis of nasopharyngeal carcinoma |
George TSAO, Hong Kong |
14:30-15:00 |
RNA biology in cancer development |
Zhi-Ming ZHENG, USA |
15:00-15:30 |
Aurora B is a novel target of human papillomavirus E6 |
Siaw S BOON, Hong Kong |
15:30-15:45 |
Coffee & poster |
Session 3.d – Clinical Practice
Chairpersons: TH CHEUNG, Hong Kong; Xuefeng LIU, USA |
15:45-16:15 |
Human papillomavirus: from bench to bedside and bedside to bench |
YL WOO, Malaysia |
16:15-16:45 |
True background of HPV vaccine crisis in Japan. Lessons learned for global immunization promotion |
Ryo KONNO, Japan |
16:45-17:15 |
The development of HPV biomarkers for disease stratification |
John DOORBAR, UK |
17:15-17:30 |
Characterization of HPV16-E7 binding affibody molecules and tumor specific imaging in HPV16 positive cervical cancer in vivo |
Lifang ZHANG, China |
17:30-17:45 |
Visualizing transcriptome dynamics of high-risk HPV oncogenes and host genes in cervical malignancies |
Kazunori NAGASAKA, Japan |
18:30-21:00 |
Gala Dinner |
|
|
|
|
|
|
|
|
|
|
|